CZC24832 PI3Kδ Inhibitor Protocol: Preparation & Assay Use

CZC24832 is a potent and selective small-molecule inhibitor of PI3Kδ (phosphoinositide 3-kinase delta) used in biochemical kinase assays and cell-based studies to investigate PI3Kδ-mediated signaling pathways.

Product Name

CZC24832

SKU

C128050

Target

PI3Kδ (Phosphoinositide 3-Kinase Delta)

Compound Class

Selective PI3Kδ small-molecule inhibitor

Recommended Solvent

DMSO (dimethyl sulfoxide)

Storage Condition

Store at -20°C, protected from light and moisture

Application

Kinase inhibition assays, cell-based signaling studies

Materials Required

Before beginning this protocol, ensure the following materials are available:

• CZC24832 (SKU: C128050, Aladdin Scientific)
• Anhydrous DMSO (≥99.9% purity, molecular biology grade)
• Appropriate aqueous assay buffer (e.g., kinase assay buffer containing HEPES or Tris-HCl, pH 7.4)
• Microcentrifuge tubes (1.5 mL or 2 mL, low-binding recommended)
• Calibrated analytical balance or micropipettes
• Vortex mixer and brief centrifuge
• Cell culture reagents (if performing cell-based assays): relevant cell lines expressing PI3Kδ, serum-free medium, stimulation agents (e.g., cytokines or growth factors)
• Personal protective equipment (lab coat, nitrile gloves, safety glasses)

Note: All concentrations and specific IC₅₀ values should be confirmed against the current Certificate of Analysis (CoA) supplied with SKU C128050 prior to use.

Stock Solution Preparation

Follow these steps to prepare a DMSO stock solution of CZC24832:

1. Equilibrate to room temperature: Allow the vial of CZC24832 (SKU: C128050) to equilibrate to room temperature (approximately 15–20 minutes) before opening, in order to prevent moisture condensation on the compound.
2. Calculate required volume: Determine the volume of DMSO needed to achieve the desired stock concentration (commonly 10 mM). Use the molecular weight provided on the CoA to calculate the exact mass-to-volume ratio.
3. Dissolve the compound: Add the calculated volume of anhydrous DMSO directly to the vial. Cap tightly and vortex for 30–60 seconds until fully dissolved. If necessary, sonicate briefly in a water bath (room temperature, ≤2 minutes).
4. Centrifuge briefly: Spin the vial at 2,000–3,000 × g for 1 minute to collect any solution from the cap and walls.
5. Aliquot and store: Divide the stock solution into single-use aliquots in low-binding microcentrifuge tubes. Store at −20°C, protected from light. Avoid repeated freeze-thaw cycles; limit to no more than three cycles.

Important: Confirm complete solubility visually before use. If precipitation is observed, warm gently and re-vortex. Do not use if the solution remains turbid.

Kinase Inhibition Assay Protocol

This section describes a general biochemical kinase inhibition assay for evaluating CZC24832 activity against PI3Kδ. Adapt assay buffer composition, enzyme concentrations, and substrate concentrations to your specific assay kit or platform.

1. Prepare working dilutions: Dilute CZC24832 stock solution in assay buffer to the desired working concentrations. Ensure that the final DMSO concentration in the assay does not exceed 0.1–1% (v/v) to avoid solvent-mediated effects on enzyme activity. Include vehicle (DMSO) control wells.
2. Pre-incubate inhibitor with enzyme: Combine CZC24832 working solution with PI3Kδ enzyme in assay buffer. Incubate for 15–30 minutes at room temperature or 37°C (per your assay kit instructions) to allow inhibitor binding equilibration.
3. Initiate the kinase reaction: Add the appropriate substrate (e.g., phosphatidylinositol or ATP-containing substrate mix) to start the reaction. Incubate for the recommended time period at 37°C.
4. Stop the reaction and detect: Terminate the reaction according to your detection platform (e.g., HTRF, luminescence, ELISA-based ADP detection). Measure signal according to the instrument manufacturer's instructions.
5. Data analysis: Calculate percent inhibition relative to vehicle control. Plot inhibition versus log[CZC24832] to determine IC₅₀ using nonlinear regression (e.g., four-parameter logistic curve fit).

Controls required: Positive control (known PI3Kδ inhibitor or maximum inhibition), negative control (vehicle only), and no-enzyme blank.

Cell-Based Assay Guidelines

CZC24832 can be applied in cell-based assays to study PI3Kδ-dependent signaling (e.g., Akt phosphorylation, downstream PIP3 production) in relevant cell models such as immune cell lines or primary leukocytes.

1. Cell seeding: Seed cells at an appropriate density in the relevant culture medium. Allow cells to adhere or equilibrate overnight (adherent cells) or rest for 1–2 hours (suspension cells).
2. Serum starvation (if applicable): For signaling assays, starve cells in serum-free medium for 2–4 hours prior to treatment to reduce basal PI3K activity.
3. Compound treatment: Add CZC24832 at the desired concentration (prepared from DMSO stock in culture medium; final DMSO ≤ 0.1% v/v). Incubate cells for 30–60 minutes at 37°C, 5% CO₂ before stimulation.
4. Stimulation: Stimulate cells with the appropriate agonist (e.g., cytokine, growth factor, or antigen receptor cross-linking) for the desired duration.
5. Sample collection and lysis: Remove medium, wash cells with ice-cold PBS, and lyse in appropriate lysis buffer supplemented with phosphatase inhibitors and protease inhibitors.
6. Readout: Quantify PI3Kδ pathway activity by Western blot (anti-pAkt Ser473 or Thr308), ELISA, or flow cytometry depending on the experimental design.

Note: Optimal CZC24832 concentrations for cell-based assays should be empirically determined through dose-response experiments, as cellular permeability and protein binding may shift effective concentrations relative to biochemical IC₅₀ values.

Troubleshooting and Safety

Troubleshooting Common Issues:

• Poor solubility: If CZC24832 does not dissolve completely in DMSO, warm the vial briefly to 37°C and vortex again. Do not add aqueous buffer before full dissolution in DMSO is confirmed.
• Precipitation in aqueous buffer: If precipitation occurs upon dilution into aqueous media, reduce the final compound concentration or increase DMSO content cautiously (while keeping it within tolerable limits for the assay). Pre-warming the buffer may help.
• Low or inconsistent inhibition: Verify stock solution integrity (check for precipitation or color change), confirm compound concentration, and ensure that the final DMSO vehicle concentration is consistent across all wells. Check that the enzyme and substrate concentrations fall within the linear range of the assay.
• High background in cell assay: Ensure phosphatase inhibitors are freshly prepared and added to lysis buffer immediately before use. Process samples on ice to minimize dephosphorylation.

Safety Information:

CZC24832 is intended for research use only and is not approved for human or veterinary therapeutic use. Handle as a potentially hazardous chemical: wear appropriate PPE (nitrile gloves, laboratory coat, and eye protection) at all times. Dispose of DMSO-containing waste according to your institution's chemical waste disposal regulations. Refer to the Safety Data Sheet (SDS) for CZC24832 (SKU: C128050) available from Aladdin Scientific for complete hazard information.

Frequently asked questions

What is the recommended solvent for dissolving CZC24832?

CZC24832 should be dissolved in anhydrous DMSO (≥99.9% purity) to prepare a stock solution, typically at 10 mM. When diluting into aqueous assay buffers or cell culture media, ensure the final DMSO concentration does not exceed 0.1–1% (v/v) to avoid cytotoxic or enzyme-inhibiting effects from the solvent.

How should CZC24832 be stored to maintain stability?

Store CZC24832 (SKU: C128050) at −20°C in a dry, dark environment, sealed tightly to exclude moisture. Aliquot the stock solution to minimize freeze-thaw cycles, which should not exceed three. Always allow the vial to reach room temperature before opening to prevent condensation. Refer to the product CoA for lot-specific stability data.

What controls should be included in a CZC24832 kinase inhibition assay?

A well-designed assay should include: (1) a vehicle control (equivalent volume of DMSO, no compound) to establish 0% inhibition baseline; (2) a positive inhibition control using a validated PI3Kδ inhibitor at saturating concentration to establish 100% inhibition; and (3) a no-enzyme blank to measure background signal. These controls enable accurate calculation of percent inhibition and IC50 determination.

Can CZC24832 be used in primary immune cells?

CZC24832 has been investigated in PI3Kδ-expressing immune cell contexts, as PI3Kδ is predominantly expressed in hematopoietic cells. However, optimal working concentrations, treatment times, and readout strategies must be empirically validated for each specific primary cell type and experimental model. Consult the current literature and confirm conditions with appropriate pilot experiments.

What is the selectivity profile of CZC24832 among PI3K isoforms?

CZC24832 is reported to be a selective inhibitor of PI3Kδ relative to other class I PI3K isoforms (PI3Kα, PI3Kβ, PI3Kγ). Researchers should consult the primary literature and the product CoA for specific selectivity ratio data, as precise selectivity fold-values require verification against the cited source material.

References

1. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nature Reviews Molecular Cell Biology. 2010;11(5):329–341. doi:10.1038/nrm2882
2. Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. Journal of Immunology. 2003;170(5):2647–2654. doi:10.4049/jimmunol.170.5.2647
3. Aladdin Scientific. CZC24832 (SKU: C128050) Certificate of Analysis and Product Data Sheet. Aladdin Scientific; [current lot].

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.